Zealand Pharma Stock Forecast - Day Typical Price

<div class='circular--portrait' style='background:#FF6600;color: #FFFAFA;font-size:4em;padding-top: 25px;;'>ZP</div>
ZEAL -- Denmark Stock  

DKK 264.00  9.80  3.86%

Zealand Pharma Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Zealand Pharma historical stock prices and determine the direction of Zealand Pharma AS future trends based on various well-known forecasting models. However, solely looking at the historical price movement is usually misleading. Macroaxis recommends to always use this module together with analysis of Zealand Pharma historical fundamentals such as revenue growth or operating cash flow patterns. Although Zealand Pharma naive historical forecasting may sometimes provide an important future outlook for the firm we recommend to always cross-verify it against solid analysis of Zealand Pharma AS systematic risk associated with finding meaningful patterns of Zealand Pharma fundamentals over time. Check out Historical Fundamental Analysis of Zealand Pharma to cross-verify your projections.

Search Stock Forecast

 
Refresh
PPandE Turnover is projected to rize to 2.82 this year. Receivables Turnover is projected to rize to 2.70 this year. Weighted Average Shares is projected to rize to about 36 M this year, although the value of Weighted Average Shares Diluted will most likely fall to about 24.6 M.
Zealand Pharma AS has current Day Typical Price of 0. Typical Price is calculated as arithmetic average of the high, low and closing price for a given trading period.
  Previous Day Typical PriceDay Typical PriceTrend
261.20
Check Zealand Pharma Volatility | Backtest Zealand Pharma | Information Ratio  

Zealand Pharma Trading Date Momentum

On June 02 2020 Zealand Pharma AS was traded for  264.00  at the closing time. The highest price during the trading period was 267.80  and the lowest recorded bid was listed for  251.80 . There was no trading activity during the period 0. Lack of trading volume on June 2, 2020 had no short-term effect on price fluctuation. The trading date delta to the current price is 4.55% .
The period considered in calculating typical price is a single trading day, however the typical price can also be applied to other time spans such as a week, month or year.
Compare Zealand Pharma to competition

Other Forecasting Options for Zealand Pharma

View Currently Related Equities

Zealand Pharma AS Technical and Predictive Analytics

Volatility Measures

Zealand Pharma Risk Indicators

Current Sentiment - ZEAL

Zealand Pharma AS Investor Sentiment

Macroaxis portfolio users are unemotional in their take regarding investing in Zealand Pharma AS. What is your take regarding investing in Zealand Pharma AS? Are you bullish or bearish?
Bullish
Bearish
50% Bullish
50% Bearish
Skip

Also Currentnly Active

<div class='circular--portrait-small' style='font-weight: 700;background:#82ADFD;color: #F0FFF0;font-size:1.1em;padding-top: 10px;;'>BC</div>
Purchased few shares of
few hours ago
Traded for 253.02
<div class='circular--portrait-small' style='font-weight: 700;background:#82ADFD;color: #F0FFF0;font-size:1.1em;padding-top: 10px;;'>BS</div>
Purchased few shares of
few hours ago
Traded for 203.46
<div class='circular--portrait-small' style='font-weight: 700;background:#82ADFD;color: #F0FFF0;font-size:1.1em;padding-top: 10px;;'>BC</div>
Purchased few shares of
few hours ago
Traded for 253.02
 2019 2020 (projected)
Long Term Debt to Equity0.2893910.297006
Interest Coverage54.2853.96
Zealand Pharma AS, a biotechnology company, engages in the discovery and development of peptide based medicines in Denmark. The company was founded in 1997 and is headquartered in Copenhagen, Denmark. Zealand Pharma operates under Biotechnology classification in Denmark and is traded on Copenhagen Stock Exchange. It employs 191 people.
Check out Historical Fundamental Analysis of Zealand Pharma to cross-verify your projections. Please also try Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page